HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients
- PMID: 11345163
HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients
Abstract
Low density lipoprotein (LDL) oxidation is a crucial step in the atherosclerotic process. High density lipoprotein (HDL)-associated enzymes such as paraoxonase could exert a protective effect on LDL oxidation in the arterial wall, an effect which could be impaired in Type 2 diabetes mellitus (T2DM). We studied copper-induced oxidation in LDL and HDL isolated from 17 T2DM patients with fair glycaemic control and HDL-cholesterol within normal range and 17 healthy normolipidaemic control subjects. To evaluate the effect of HDL on LDL oxidation in diabetic and control subjects, we assessed copper-induced oxidation in HDL/LDL mixtures, with each lipoprotein isolated from the same subject. Relationships with HDL chemical composition, alpha-tocopherol content and serum paraoxonase activity were investigated. Oxidation was promoted by lipoprotein incubation with copper and then thiobarbituric acid reactive substances (TBARS), conjugated diene production and electrophoretic mobility in agarose gel were measured. In T2DM subjects HDL oxidation was higher than in controls. However, HDL from diabetics was as effective as control HDL to inhibit LDL oxidation. Neither HDL chemical composition nor serum paraoxonase activity showed any difference as compared to control subjects. In contrast, HDL from T2DM subjects showed a higher alpha-tocopherol content which positively correlated with HDL oxidability. Paraoxonase activity positively and strongly correlated with HDL inhibitory effect on LDL oxidation in patients and controls belonging to the heterozygous activity phenotype. Besides, LDL oxidability showed no differences between patients and controls. These results suggest that fairly-controlled T2DM patients with HDL-cholesterol levels within normal range show: 1) normal HDL ability to inhibit LDL oxidation related to normal paraoxonase activity; 2) higher HDL oxidability in spite of its high alpha-tocopherol content, which could favour tocopherol-mediated peroxidation and 3) normal LDL oxidability possibly due to the lack of significant lipoprotein structural alterations.
Similar articles
-
HDL capacity to inhibit LDL oxidation in well-trained triathletes.Life Sci. 2006 May 22;78(26):3074-81. doi: 10.1016/j.lfs.2005.12.015. Epub 2006 Feb 20. Life Sci. 2006. PMID: 16488445
-
Impaired high density lipoprotein antioxidant activity in healthy postmenopausal women.Atherosclerosis. 2004 Nov;177(1):203-10. doi: 10.1016/j.atherosclerosis.2004.07.011. Atherosclerosis. 2004. PMID: 15488885
-
Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.J Clin Invest. 1998 Apr 15;101(8):1581-90. doi: 10.1172/JCI1649. J Clin Invest. 1998. PMID: 9541487 Free PMC article.
-
HDL and LDL cholesterol significantly influence beta-cell function in type 2 diabetes mellitus.Curr Opin Lipidol. 2010 Jun;21(3):178-85. doi: 10.1097/MOL.0b013e328339387b. Curr Opin Lipidol. 2010. PMID: 20463468 Review.
-
Oxidized LDL and HDL: antagonists in atherothrombosis.FASEB J. 2001 Oct;15(12):2073-84. doi: 10.1096/fj.01-0273rev. FASEB J. 2001. PMID: 11641234 Review.
Cited by
-
High-Density Lipoprotein Alterations in Type 2 Diabetes and Obesity.Metabolites. 2023 Feb 9;13(2):253. doi: 10.3390/metabo13020253. Metabolites. 2023. PMID: 36837872 Free PMC article. Review.
-
Elevated Levels of Serum β2-Glycoprotein I/Oxidized Low-Density Lipoprotein Complexes Are Associated with Cerebral Infarction in Patients with Type 2 Diabetes Mellitus.Med Sci Monit. 2018 Feb 28;24:1232-1240. doi: 10.12659/msm.907078. Med Sci Monit. 2018. PMID: 29489742 Free PMC article.
-
Antioxidative activity of high-density lipoprotein (HDL): Mechanistic insights into potential clinical benefit.BBA Clin. 2017 Aug 19;8:66-77. doi: 10.1016/j.bbacli.2017.07.002. eCollection 2017 Dec. BBA Clin. 2017. PMID: 28936395 Free PMC article. Review.
-
HDL therapy for cardiovascular diseases: the road to HDL mimetics.Curr Atheroscler Rep. 2008 Oct;10(5):405-12. doi: 10.1007/s11883-008-0063-6. Curr Atheroscler Rep. 2008. PMID: 18706282 Review.
-
The therapeutic efficacy of intensive medical therapy in ameliorating high-density lipoprotein dysfunction in subjects with type two diabetes.Lipids Health Dis. 2016 Aug 27;15(1):141. doi: 10.1186/s12944-016-0314-4. Lipids Health Dis. 2016. PMID: 27567897 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical